Results 121 to 130 of about 24,077 (195)

[The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang LW, Zhang QG, Ji MC, Qi KM, Li ZY, Xu KL, Fu CL.   +6 more
europepmc   +1 more source

Four Cases of Myeloproliferative Disorders Associated With Down Syndrome: Distinguishing ML-DS From TAM-DS: Distinguishing TAM-DS and ML-DS: Report of 4 Cases. [PDF]

Case Rep Hematol
Boumeghar K, Daliphard S, Buchbinder N, Boutet C, Penther D, Etancelin P, Bourgain J, Buchonnet G, Bera E, Bobée V.   +9 more
europepmc   +1 more source

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population. [PDF]

Asian Pac J Cancer Prev, 2019
Syeed N.
europepmc   +1 more source

Pairing JAK with MEK for improved therapeutic efficiency in myeloproliferative disorders. [PDF]

J Clin Invest, 2019
Williams DA.
europepmc   +1 more source

Myelodysplastic and myeloproliferative disorders of childhood. [PDF]

Hematology Am Soc Hematol Educ Program, 2016
Hasle H.
europepmc   +1 more source

Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders. [PDF]

Clin Appl Thromb Hemost, 2018
Yildiz A, Güryildirim M, Pepeler MS, Yazol M, Oktar SÖ, Acar K.   +5 more
europepmc   +1 more source

Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders. [PDF]

J Natl Compr Canc Netw, 2017
McFarland DC, Shaffer KM, Polizzi H, Mascarenhas J, Kremyanskaya M, Holland J, Hoffman R.   +6 more
europepmc   +1 more source

Myocardial infarction as a thrombotic complication of myeloproliferative disorders. [PDF]

Anatol J Cardiol, 2016
Petrou E, Karali V.
europepmc   +1 more source

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. [PDF]

Blood Adv, 2018
Sengsayadeth S, Gatwood KS, Boumendil A, Labopin M, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gilleece MH, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A.   +24 more
europepmc   +1 more source

Pulmonary hypertension in patients with chronic myeloproliferative disorders. [PDF]

Eur Respir Rev, 2015
Adir Y, Elia D, Harari S.
europepmc   +1 more source